Health Care & Life Sciences » Biotechnology | QuantRx Biomedical Corp.

QuantRx Biomedical Corp. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
6.10
2.40
0.20
-
-
235.90
Cost of Goods Sold (COGS) incl. D&A
9.80
11.60
9.70
7.20
10.90
-
Gross Income
3.70
9.20
9.50
7.20
10.90
-
SG&A Expense
373.30
453.30
349.20
131.70
154.30
235.90
EBIT
377.00
462.50
358.70
138.80
165.20
235.90
Unusual Expense
0.50
66.50
-
80.10
169.90
169.60
Non Operating Income/Expense
64.80
26.70
57.10
17.00
1,457.50
100.30
Interest Expense
59.30
329.00
166.10
196.10
253.20
232.20
Pretax Income
358.30
827.00
467.80
398.00
869.10
736.90
Consolidated Net Income
358.30
827.00
467.80
398.00
869.10
736.90
Net Income
358.30
827.00
467.80
398.00
869.10
736.90
Net Income After Extraordinaries
358.30
827.00
467.80
398.00
869.10
736.90
Net Income Available to Common
358.30
827.00
467.80
398.00
869.10
736.90
EPS (Basic)
0.01
0.01
0.01
0.01
0.01
0.01
Basic Shares Outstanding
52,563.20
58,805.40
66,834.70
74,246.90
78,696.50
78,696.50
EPS (Diluted)
0.01
0.01
0.01
0.01
0.01
0.01
Diluted Shares Outstanding
52,563.20
58,805.40
66,834.70
74,246.90
130,534.40
78,696.50
EBITDA
367.80
452.80
349.00
131.70
154.30
235.90
Non-Operating Interest Income
13.70
4.40
-
-
-
1.10

About QuantRx Biomedical

View Profile
Address
10190 SW 90th Avenue
Tualatin Oregon 97123
United States
Employees -
Website http://quantrx.com/Overview.htm
Updated 07/08/2019
QuantRx Biomedical Corp. engages in the development and commercializing of patented miniform pads (PAD) and PAD based over-the-counter products for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and medical needs. Its platforms include inSync(R), Unique(TM), PadKit(R), and OEM branded over-the-counter and laboratory testing products. The company was founded on December 5, 1986 and is headquartered in Tualatin, OR.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.